Laura Campbell Trust v. John Hancock Life Ins. Co.

• Decision Date: 02 February 2006
• Docket Number: No. CIV. AMD 05-885.,CIV. AMD 05-885.
• Citation: 411 F.Supp.2d 606
• Parties: The LAURA CAMPBELL TRUST, Plaintiff v. JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.), Defendant.
• Court: U.S. District Court — District of Maryland

411 F.Supp.2d 606

The LAURA CAMPBELL TRUST, Plaintiff v. JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.), Defendant.

No. CIV. AMD 05-885.

United States District Court, D. Maryland.

February 2, 2006.

COPYRIGHT MATERIAL OMITTED

Catherine A. Potthast, Nolan Plumhoff and Williams Chtd., Towson, MD, for Plaintiff.

John Snowden Stanley, Jr., Semmes Bowen and Semmes PC, Baltimore, MD, for Defendant.

MEMORANDUM OPINION

DAVIS, District Judge.

In this lawsuit, the Laura Campbell Trust¹ (the "Trust") seeks to recover the proceeds of a $750,000 life insurance policy. Defendant John Hancock Life Insurance Company ("the company") issued the policy on Dec. 26, 2002, to the insured, Dr. Joella Campbell.² After Dr. Campbell died, however, the company denied the claim, rescinded the policy and returned all premiums that had been paid. Consequently, the Trust filed this case for breach of contract in the Circuit Court for Baltimore County, from which defendant timely removed the case to this court.

Discovery having concluded, defendant now moves for summary judgment. The company has put forth the following arguments for denying the claim: (1) Dr. Campbell made a material misrepresentation in the insurance application and in doing so concealed the fact that she had been hospitalized with a serious medical condition; and (2) the policy never became effective because Dr. Campbell never fulfilled the condition precedent that there be no deterioration in her health between the date of the application and the delivery of the policy. The Trust refutes these assertions and argues that the insurer is precluded from denying coverage by the doctrine of equitable estoppel. No hearing is needed; the motion shall be granted for the reasons stated below.

I.

Dr. Campbell started looking into life insurance policies in Summer 2002, when she was 73 years old, so she could provide for her disabled daughter, Laura. She initiated the process through Keith Burgess, an appointed agent of the company's predecessor, Manufacturer's Life Insurance Company. As part of that process, Burgess arranged for Dr. Campbell to get a medical examination on July 18, 2002. She also agreed to make her medical records available to the company. The examination and records review indicated that Dr. Campbell had myriad health problems, including gastroesophageal reflux disease, a benign goiter, arthritis of the hips, high cholesterol, cancer (which apparently had been treated with some success) and an abnormally high heart rate. Dr. Campbell filled out an application on Oct. 2, 2002.

While the October 2002 application was being considered by the underwriter, Dr. Campbell decided that it was in her best interest not to be the owner of the proposed policy. Instead, she and her attorney, Gary Aiken, Esq., established a trust with Aiken serving as the trustee and the Laura Campbell Trust as the beneficiary. Consequently, Dr. Campbell had to submit a new application.

The new application was dated November 21, 2002, and was signed by Dr. Campbell with the agent, Burgess, as the witness. Of particular note here, Question 22 asked when the applicant last visited her regular doctor and the reason for the visit. Dr. Campbell answered that she had not seen her doctor in six months, when she went for a check-up. In reality, however, Dr. Campbell had been to see her doctor on November 19, 2002, as a follow-up to her October hospitalization for congestive heart failure, unresolved pneumonia and hypothyroidism. Nevertheless, the policy was issued on December 26, 2002, and the company delivered it to Dr. Campbell the next day.

Dr. Campbell died on March 21, 2004, of lung cancer with metastasis. A claim was filed with the company in June 2004. The company conducted a routine review. When it discovered that Dr. Campbell had falsely answered Question 22, the company denied the claim, rescinded the policy, and returned the premium payments (totaling $52,380).

II.

Pursuant to Rule 56(c) of the Federal Rules of Civil Procedure, summary judgment is appropriate "if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law." Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). A fact is material for purposes of summary judgment, if, when applied to the substantive law, it affects the outcome of the litigation. Id. at 248, 106 S.Ct. 2505. Summary judgment is also appropriate when a party "fails to make a showing sufficient to establish the existence of an element essential to that party's case, and on which that party will bear the burden of proof at trial." Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986); Karim v. Staples, Inc., 210 F.Supp.2d 737, 740 (D.Md.2002).

III.

A.

The insurer argues that Dr. Campbell made a material misrepresentation when she stated in Question 22 of the insurance application that she had not visited her doctor in the prior six months. In fact, Dr. Campbell had visited her doctor two days prior to the date on the application as a follow-up to her then-undisclosed hospitalization.

The parties agree that Virginia law applies in this case. Under Virginia law, an insurer seeking to void a policy because of a misrepresentation, must prove "(1) that the statement or omission on the application was untrue; and (2) that the insurance company's reliance on the false statement or omission was material to the company's decision to undertake the risk and issue the policy." Montgomery Mutual Insurance Company v. Riddle, 266 Va. 539, 587 S.E.2d 513, 515 (2003); see VA. CODE ANN. § 38.2-309 (West 2005).

Although it would seem obvious that the disputed statement was not true, the Trust goes to great lengths to challenge this. The Trust argues that a genuine dispute of fact exists over whether (1) Dr. Campbell signed a blank document that was filled out later by Burgess; or (2) the application was completed and signed prior to the date of Dr. Campbell's undisclosed visit to her doctor. This effort ultimately fails, however, because the Trust has no probative evidence of these possibilities. What the Trust offers in this regard amounts to "propensity evidence" — that is, because in the past Burgess had Dr. Campbell sign blank documents, or misdated forms, he is likely to have done the same in this instance.³ Meanwhile, Burgess stated quite clearly in his deposition that, in fact, Dr. Campbell signed the completed application in his presence on November 21, 2002. Burgess Depo. at 91. There is no witness to contradict this. Accordingly, there exists no genuine dispute of material fact as to whether the statement on the application was untrue.

As a matter of law, moreover, the information omitted by Dr. Campbell was material. "A fact is material to the risk to be assumed by an insurance company if the fact would reasonably influence the company's decision whether or not to issue a policy." Harrell v. North Carolina Mutual Life Insurance Co., 215 Va. 829, 213 S.E.2d 792, 794-95 (1975) (quoting Mutual of Omaha Ins. Co. v. Echols, 207 Va. 949, 154 S.E.2d 169, 172 (1967)); and see id. at 794 (stating that materiality is a question of law for the court).

In the instant case, the company clearly states that it relied on the information from Question 22 in making its decision — and that if it had known the truthful answer, it would have denied coverage. See Affidavit of Morag Baker, assistant vicepresident of underwriting, John Hancock Life Insurance.

The Trust strenuously argues that the Question 22 misrepresentation was immaterial. First, plaintiff argues that Morag Baker initially stated in her deposition that she was not aware if an underwriter had reviewed the second Campbell application. See Baker Depo. at 123. While this is true, Baker later stated in an appendix to her deposition that, after reviewing the "image file" she could confirm that it had been reviewed by an underwriter.

The Trust also argues that Question 22 was an optional question — and for that reason it cannot possibly be material. This is factually correct in the sense that the application states, immediately above Question 22, "Complete only if Health Questionnaire NB3502 is NOT being submitted." Furthermore, Dr. Campbell did submit the specified questionnaire. However, the attached questionnaire was prepared for the October 2, 2002, application, and therefore it is reasonable that an underwriter would rely on Question 22 to update the file. This argument would be stronger, perhaps, if a questionnaire had been prepared specifically for the November 21 application. Regardless, the fact is that Dr. Campbell answered the question, and therefore it is reasonable that the company would rely on it. If, for example, Dr. Campbell had stated in the "optional" question that she had been diagnosed with brain cancer and had a week to live, that would have been material regardless of whether the question was optional or mandatory.

In making the above arguments about materiality, the Trust fails to address what ultimately should be the most important consideration in determining the materiality of Question 22. That is, what matters most is identification of the information that should have been produced. In other words, to show that Question 22 was immaterial, the Trust might have demonstrated that the medical ailments the question would have brought to light likely would not have affected the decision of whether to issue the policy. Because Dr. Campbell was known to be in poor health from the outset, the Trust could have offered expert testimony that the additional ailments were insignificant. But, because the Trust fails to do so, the court is not in a position to call onto question the company's assertion that it would not have issued the policy if it had...